BioMarin Pharmaceutical Inc (NASDAQ:BMRN) CEO Jean Jacques Bienaime sold 1,545 shares of the stock on the open market in a transaction dated Wednesday, May 21st. The stock was sold at an average price of $56.19, for a total transaction of $86,813.55. Following the transaction, the chief executive officer now directly owns 180,257 shares of the company’s stock, valued at approximately $10,128,641.BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) net profit margin is -30.50% and weekly performance is -2.16%. On last trading day company shares ended up $56.20. Analysts mean target price for the company is $82.61. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) distance from 50-day simple moving average (SMA50) is -12.28%.
Amgen Inc (NASDAQ:AMGN) CAO Thomas J.W. Dittrich sold 4,130 shares of Amgen stock on the open market in a transaction dated Wednesday, May 21st. The stock was sold at an average price of $112.83, for a total value of $465,987.90. Following the completion of the sale, the chief accounting officer now directly owns 18,589 shares in the company, valued at approximately $2,097,397. Amgen, Inc. (NASDAQ:AMGN) shares advanced 1.21% in last trading session and ended the day on $114.86. Gross Margin is 82.70% and its return on assets is 7.80%. Amgen, Inc. (NASDAQ:AMGN) quarterly performance is -6.75%.
Alexion Pharmaceuticals Inc (NASDAQ:ALXN) EVP Martin Mackay sold 3,574 shares of Alexion Pharmaceuticals stock in a transaction dated Wednesday, May 14th. The shares were sold at an average price of $160.85, for a total transaction of $574,877.90. Following the transaction, the executive vice president now directly owns 24,426 shares in the company, valued at approximately $3,928,922. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares moved up 2.48% in last trading session and was closed at $160.48, while trading in range of $156.53 – $164.50. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) year to date (YTD) performance is 20.77%.
Anacor Pharmaceuticals Inc (NASDAQ:ANAC) SVP Kirk R Maples sold 1,500 shares of Anacor Pharmaceuticals stock in a transaction dated Tuesday, May 20 th. The shares were sold at an average price of $ 14.15, for a total transaction of $ 21,225.00. Anacor Pharmaceuticals Inc (NASDAQ:ANAC) ended the last trading day at $14.61. Company weekly volatility is calculated as 5.95% and price to cash ratio as 4.07. Anacor Pharmaceuticals Inc (NASDAQ:ANAC) showed a positive weekly performance of 3.91%.
Leave a Reply